CHFR Enhances The Drug Sensitivity Of Paclitaxel In Oral Cancer Cells
CHFR enhances paclitaxel sensitivity in oral cancer cells by downregulating NF-κB, effectively inhibiting tumor cell activity and suppressing tumor progression.
Institutions
- Air Force General Hospital PLA (CN)
Publication Details
- Journal
- Pakistan Journal of Pharmaceutical Sciences
- Published
- 2025-12-05
- DOI
- https://doi.org/10.36721/pjps.2026.39.1.reg.13848.1
- Primary Topic
- Cancer Mechanisms and Therapy
- Type
- article
- Field-Weighted Citation Impact
- 0.00